EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ENGINEUSEFFECT was filed as Word mark on 11/19/2015 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/10/2016.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 014818901 |
| Application date | November 19, 2015 |
| Publication date | December 1, 2015 |
| Entry date | June 10, 2016 |
| Expiration date | November 19, 2025 |
Trademark owner
Kurfürsten-Anlage 21
69115 Heidelberg
DE
69115 Heidelberg
DE
Trademark representatives
Prinzregentenstr. 68
81675 München
DE
goods and services
9
Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology; downloadable computer databases containing medical and/or health information or records about or relating to humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans; downloadable mobile applications for mobile devices, such as eg smart phones and/or tablet computers, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans; medical or laboratory software, including data, databases and algorithms, for DNA and genome analysis in disease diagnostics, for the diagnosis of genomic changes and tests at the molecular level, in particular laboratory software for next generation sequencing (NGS), in particular laboratory software, including data, databases and algorithms, for next generation sequencing (NGS) in the context of clinical and medical applications, and software, including data, databases and algorithms, for assisting medical or research decisions for diagnostic and therapeutic applications; medical software, including data, databases and algorithms, for pharmacological, pharmacogenetic, molecular and/or biochemical analysis of substances and medicines, in particular for the analysis of the action mechanisms of pharmaceutical preparations, in particular in the field of medicine safety and medicine compatibility; laboratory software, including data, databases and algorithms, for high resolution and/or highly sensitive analysis of DNA or genomes; medical or laboratory software, including data, databases and algorithms, for toxicity research in relation to pharmaceutical preparations; medical or laboratory software, including data, databases and algorithms, for analysis of resistance to pharmaceutical preparations
10
Medical or laboratory device, apparatus and/or equipment for DNA and genome analysis in disease diagnostics, including but not limited to cancer diagnostics, for the diagnosis of genomic changes and tests at the molecular level, in particular laboratory device, apparatus and equipment for next generation sequencing (NGS), in particular laboratory device, apparatus and equipment for next generation sequencing (NGS) in the context of clinical and medical applications, and device, apparatus, equipment and/or instruments for assisting medical or research decisions for diagnostic and therapeutic applications; medical device, apparatus and/or equipment for pharmacological, pharmacogenetic, molecular and/or biochemical analysis of substances and medicines, in particular for the analysis of the action mechanisms of pharmaceutical preparations, in particular in the field of medicine safety and medicine compatibility; laboratory device, apparatus and/or equipment for high resolution and/or highly sensitive analysis of DNA or genomes; medical or laboratory device, apparatus and/or equipment for toxicity research in relation to pharmaceutical preparations; medical or laboratory device, apparatus and/or equipment for analysis of resistance to pharmaceutical preparations
38
Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development; providing access to safety information, including an integrated approach to identify the interactions and adverse events related to specific drugs, drug classes, diseases, and molecular targets and pathways; providing access to drug safety information, including relationships between scientific findings and diverse events, including relationships between drugs, toxicity mechanisms, patient susceptibility, and clinical effects, including identification of actual and predicted drug safety concerns; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing access to databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes
42
Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, genomics and/or pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing, and/or molecular data, disease, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; compilation of data for basic research and for analytical purposes, in particular compilation of mathematical and statistical data, clinical data, data relating to genome analysis of patients and data from clinical studies relating to the clinical reaction behavior of a patient to certain medication and treatment methods; designing and/or developing and/or providing use of searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; designing and/or developing and/or use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development; designing and/or developing and/or providing use of safety information, including an integrated approach to identify the interactions and adverse events related to specific drugs, drug classes, diseases, and molecular targets and pathways; designing and/or developing drug safety information, including relationships between scientific findings and diverse events, including relationships between drugs, toxicity mechanisms, patient susceptibility, and clinical effects, including identification of actual and predicted drug safety concerns; designing and/or developing and/or providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; research or consulting services featuring software under a software as a Service (SaaS) model for enabling the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and molecular data, disease information, biomarker information, drug protocols, drug interactions, clinical profiles, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research and/or health and/or medical information, records or data for medical, diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; provision of mobile applications for mobile devices, such as eg smart phones and tablets, and web applications accessible through the Internet in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing safety information, including an integrated approach to identify the interactions and adverse events related to specific drugs, drug classes, diseases, and molecular targets and pathways; providing drug safety information, including relationships between scientific findings and diverse events, including relationships between drugs, toxicity mechanisms, patient susceptibility, and clinical effects, including identification of actual and predicted drug safety concerns; providing information in the fields of life sciences, biotechnology, and bioinformatics
44
Consulting services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing pharmacological information, in particular relating to medicine safety and active ingredient compatibility in cancer therapy and the treatment of individuals; providing use of databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes; consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing information in the fields of health, healthcare, pharmaceuticals and pharmaceutical safety, genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing pharmaceutical information, including information about drug safety and/or drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 16, 2019 | Change Representative, Published | ||
| January 16, 2019 | Change Representative, Published | ||
| December 1, 2015 | Transfer / Change of address, Published |
ID: 11014818901